Summary by Moomoo AI
Conduit Pharmaceuticals Inc. has entered into a series of financial agreements to secure funding for its operations. On October 29, 2024, the company signed a Bridge Loan Agreement with A.G.P./Alliance Global Partners, receiving an advance of up to $600,000 and issuing warrants for purchasing approximately 2.86 million shares of its common stock. The warrants have an exercise price of $0.1048 per share, with stockholder approval required for the exercise. A stockholder meeting is planned within 90 days to seek this approval. The Bridge Note associated with this loan has an interest rate of 4.21% and is due by December 31, 2024. Additionally, Conduit Pharmaceuticals has amended a previous fee agreement with A.G.P., suspending a 25% net proceeds payment obligation until the Bridge Note is fully...Show More
